NAVASYS Trademark

Trademark Overview


On Monday, January 5, 2015, a trademark application was filed for NAVASYS with the United States Patent and Trademark Office. The USPTO has given the NAVASYS trademark a serial number of 79167251. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, October 7, 2022. This trademark is owned by NITTO DENKO CORPORATION. The NAVASYS trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Adhesive bands for medical purposes; adhesive plasters for medical purposes; adhesive tapes for medical purposes; adjuvants for medical purposes; bacterial poisons; bacterial preparations for medical or veterinary use; bacteriological preparations for medical or veterinary use; biological preparations for medical purposes for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; biological preparations for veterinary purposes for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; capsules for medicines in the nature of capsules containing medicine for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; chemical preparations for medical purposes, namely, for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other diseas...

Bacterial preparations other than for medical or veterinary use; biological preparations, other than for medical or veterinary purposes; chemical preparations for analyses in laboratories, namely, chemical preparations for scientific purposes, chemical preparations for use in industry other than for medical or veterinary purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical reagents for scientific purposes other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, namely, chemical preparations for scientific purposes, chemical preparations for use in industry other than for medical or veterinary purposes; chemicals comprising glycolipid structure, namely, glycolipid for use in pharmaceutical preparations; cultures of microorganisms, other than for medical and veterinary use; industrial chemicals; lipopolysaccharide; preparations of mic...
navasys

General Information


Serial Number79167251
Word MarkNAVASYS
Filing DateMonday, January 5, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, October 7, 2022
Registration Number4920192
Registration DateTuesday, March 22, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 5, 2016

Trademark Statements


Goods and ServicesAdhesive bands for medical purposes; adhesive plasters for medical purposes; adhesive tapes for medical purposes; adjuvants for medical purposes; bacterial poisons; bacterial preparations for medical or veterinary use; bacteriological preparations for medical or veterinary use; biological preparations for medical purposes for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; biological preparations for veterinary purposes for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; capsules for medicines in the nature of capsules containing medicine for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; chemical preparations for medical purposes, namely, for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; chemical preparations for pharmaceutical purposes, namely, for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; chemical preparations for veterinary purposes, namely, for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; chemical reagents for medical or veterinary purposes; chemico-pharmaceutical preparations, namely, for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; chewing gum for medical purposes; collyrium; medicated compresses; cultures of microorganisms for medical and veterinary purposes; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drugs for medical purposes, namely, pharmaceutical preparations for the prevention of the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; Immunomodulators, namely, lipopolysaccharides, toll-like receptor (TLR) ligands, cyclic dinucleotide, bestatin in the nature of Ubenimex pidotimod as an immunostimulant, levamisole hydrochloride, cyclooxygenase inhibitor, prostaglandin receptor antagonist, prostaglandin receptor agonist, Thymic stromal lymphopoietin (TSLP) production inhibitor, adenylate cyclase inhibitor, omega-3 fatty acid, peroxisome proliferator-activated receptor (PPAR) agonist, dopamine receptor antagonist, dopamine receptor agonist, histamine receptor agonist, histamine receptor antagonist, serotonin receptor agonist, serotonin receptor antagonist, vasopressin receptor antagonist, vasopressin receptor agonist, muscarine receptor antagonist, muscarine receptor agonist, adrenergic receptor antagonist, adrenergic receptor agonist, angiotensin receptor agonist, GABA receptor agonist, thrombin receptor antagonist, thrombin receptor agonist, opioid receptor agonist, Adenosine diphosphate (ADP) receptor agonist, leukotriene receptor antagonist, leukotriene receptor agonist, melatonin receptor agonist, somatostatin receptor agonist, cannabinoid receptor agonist, sphingosine-1 phosphate receptor agonist, metabotropic glutamate receptor agonist, phospholipase A2 inhibitor, TGF-ß production inhibitor, and Th2 cytokine inhibitor all for the treatment and prevention of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; immunosuppressive agent, namely, pharmaceutical preparations in the nature of lipopolysaccharide, toll-like receptor (TLR) ligands, cyclic dinucleotide, bestatin in the nature of Ubenimex pidotimod as an immunostimulant, levamisole hydrochloride, cyclooxygenase inhibitor, prostaglandin receptor antagonist, prostaglandin receptor agonist, Thymic stromal lymphopoietin (TSLP) production inhibitor, adenylate cyclase inhibitor, omega-3 fatty acid, peroxisome proliferator-activated receptor (PPAR) agonist, dopamine receptor antagonist, dopamine receptor agonist, histamine receptor agonist, histamine receptor antagonist, serotonin receptor agonist, serotonin receptor antagonist, vasopressin receptor antagonist, vasopressin receptor agonist, muscarine receptor antagonist, muscarine receptor agonist, adrenergic receptor antagonist, adrenergic receptor agonist, angiotensin receptor agonist, GABA receptor agonist, thrombin receptor antagonist, thrombin receptor agonist, opioid receptor agonist, Adenosine diphosphate (ADP) receptor agonist, leukotriene receptor antagonist, leukotriene receptor agonist, melatonin receptor agonist, somatostatin receptor agonist, cannabinoid receptor agonist, sphingosine-1 phosphate receptor agonist, metabotropic glutamate receptor agonist, phospholipase A2 inhibitor, TGF-ß production inhibitor, and Th2 cytokine inhibitor all for the treatment and prevention of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; lotions for pharmaceutical purposes for skin, mucosal membrane, and body; lotions for veterinary purposes for skin, mucosal membrane, and body; medicated lozenges for pharmaceutical purposes; medical plasters; medicinal drinks; medicines for dental purposes; medicines for human purposes, namely, pharmaceutical preparations for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; medicines for veterinary purposes, namely, pharmaceutical preparations for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; mouthwashes for medical purposes; ointments for pharmaceutical purposes, namely, vaccines; oral vaccine preparations; medicated pastilles for pharmaceutical purposes; petroleum jelly for medical purposes; pharmaceutical preparations for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for skin care; pomades for medical purposes; poultices; Pharmaceutical preparations for therapy of immunity for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; preparations of microorganisms for medical and veterinary purposes the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; siccatives for medical purposes; sticking plasters for medical purposes; syrups for pharmaceutical purposes for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; therapeutic drug for therapy of immunity, namely, vaccines; tissues impregnated with pharmaceutical lotions for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; vaccine adjuvants; vaccine preparations; vaccines; vaccines against influenza; vaccines against pneumococcal infections; vaccines for cattle; vaccines for dogs; vaccines for horses; vaccines for human or animal; vaccines for human use; vaccines or preparations used in the treatment of cancer; veterinary vaccines
Goods and ServicesBacterial preparations other than for medical or veterinary use; biological preparations, other than for medical or veterinary purposes; chemical preparations for analyses in laboratories, namely, chemical preparations for scientific purposes, chemical preparations for use in industry other than for medical or veterinary purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical reagents for scientific purposes other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, namely, chemical preparations for scientific purposes, chemical preparations for use in industry other than for medical or veterinary purposes; chemicals comprising glycolipid structure, namely, glycolipid for use in pharmaceutical preparations; cultures of microorganisms, other than for medical and veterinary use; industrial chemicals; lipopolysaccharide; preparations of microorganisms, namely, cultures of microorganisms, other than for medical and veterinary use
Translation of Words in MarkThe wording "NAVASYS" has no meaning in a foreign language.

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 7, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 7, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNITTO DENKO CORPORATION
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameNITTO DENKO CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameNITTO DENKO CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Monday, July 31, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, July 11, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, July 11, 2023INVALIDATION PROCESSED
Wednesday, June 7, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, October 7, 2022CANCELLED SECTION 71
Friday, July 15, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, June 22, 2016FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, June 22, 2016FINAL DISPOSITION PROCESSED
Wednesday, June 22, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 22, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, January 5, 2016PUBLISHED FOR OPPOSITION
Monday, January 4, 2016NOTIFICATION PROCESSED BY IB
Wednesday, December 16, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 16, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 16, 2015NOTICE OF PUBLICATION
Monday, November 30, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 20, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 20, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 20, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 13, 2015ASSIGNED TO LIE
Monday, October 26, 2015TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, September 21, 2015FINAL REFUSAL MAILED
Friday, September 18, 2015FINAL REFUSAL WRITTEN
Friday, August 28, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 28, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 28, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, July 11, 2015REFUSAL PROCESSED BY IB
Tuesday, June 30, 2015APPLICATION FILING RECEIPT MAILED
Thursday, June 25, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, June 25, 2015REFUSAL PROCESSED BY MPU
Thursday, June 25, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, June 24, 2015NON-FINAL ACTION WRITTEN
Wednesday, June 24, 2015ASSIGNED TO EXAMINER
Wednesday, June 24, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 18, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB